OX40/OX40L: Broadly Involved in Inflammation, Autoimmunity, and Cancer
OX40 is gaining momentum as a high-value target in next-generation immunomodulation.
With its pivotal role in T cell co-stimulation and involvement in both oncology and autoimmune diseases, OX40 has attracted increasing clinical attention. Multiple assets targeting this pathway are advancing through late-stage trials, marking a new wave of immune-focused therapeutic strategies.
2025-07-24